Abstract
Impact of PROphet Assay in Changing Physician’s Therapeutic Decision-Making for Checkpoint Immunotherapy in NSCLC (Non-Small Cell Lung Cancer)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have